{
    "organizations": [],
    "uuid": "5386c258938d44d752db52a70f2d3084d33f6e20",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-reata-announces-that-kyowa-hakko-k/brief-reata-announces-that-kyowa-hakko-kirin-received-sakigake-priority-review-designation-for-bardoxolone-methyl-in-japan-idUSFWN1RB0Z3",
    "ord_in_thread": 0,
    "title": "Reata Announces That Kyowa Hakko Kirin Received Sakigake Priority Review Designation For Bardoxolone Methyl In Japan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Reata Pharmaceuticals Inc:\n* REATA ANNOUNCES THAT KYOWA HAKKO KIRIN RECEIVED SAKIGAKE PRIORITY REVIEW DESIGNATION FOR BARDOXOLONE METHYL IN JAPAN Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-30T04:29:00.000+03:00",
    "crawled": "2018-03-30T12:57:21.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "reata",
        "pharmaceutical",
        "inc",
        "reata",
        "announces",
        "kyowa",
        "hakko",
        "kirin",
        "received",
        "sakigake",
        "priority",
        "review",
        "designation",
        "bardoxolone",
        "methyl",
        "japan",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}